Atlas Trials

Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma

Clinical trial NCT00492076 · COMPLETED

Trial details

NCT number
NCT00492076
Sponsor
ALK-Abelló A/S
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Allergic Asthma
Start date
2006-10-01
Primary completion
2008-05-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.